VL

Venkata Laxmi Irukulla

Active Director Director DIN 08876827
DIN 08876827 First appointment Sep 2020 Primary industry Real Estate and Construction
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Sep 2020
Shareholding value •••• Premium profile

About Venkata Laxmi Irukulla

Data last updated:

Venkata Laxmi Irukulla is a Director at Sri Rama Surya Constructions Private Limited (since 2022), Director at Wiwin Health Care Private Limited (since 2024) and Director at Concresco Pharma Technologies Private Limited (since 2023). The companies operate in Real Estate and Construction, Research & Development and Paper. The 2 current companies with reported revenue have a combined latest revenue of ₹1.25 Cr; the largest is Sri Rama Surya Constructions Private Limited at ₹76.1 Lakh (FY 2025). Earlier, Venkata Laxmi Irukulla was a Director at Neuheit Pharma Technologies Private Limited (2020–2024) and Designated Partner at Atindriya Solutions Llp (from 2021).

DIN 08876827
Primary Designation Director
Industry Real Estate and Construction
First Appointment 14 Sep 2020
Oldest Company Age 5 yrs
Largest company Sri Rama Surya Constructions Private Limited · ₹76.1 Lakh (FY 2025)
Combined revenue ₹1.25 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Jul 20222021₹76.1 Lakh (FY 2025)Active
Wiwin Health Care Private Limited U73100TG2022PTC158705
Director22 Jul 20242022₹48.8 Lakh (FY 2024)Active
Director16 Aug 20232023Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director14 Sep 20202013₹18.44 Cr (FY 2025)Active
Designated Partner09 Nov 20212021Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sri Rama Surya Constructions Private Limited
Atindriya Solutions Llp
Wiwin Health Care Private Limited
Concresco Pharma Technologies Private Limited
Premium access

Shareholding and investment profile for Venkata Laxmi Irukulla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Venkata Laxmi Irukulla

Venkata Laxmi Irukulla currently holds 3 directorships: Sri Rama Surya Constructions Private Limited (Director, since 01 Jul 2022, revenue ₹76.1 Lakh (FY 2025)); Wiwin Health Care Private Limited (Director, since 22 Jul 2024, revenue ₹48.8 Lakh (FY 2024)); Concresco Pharma Technologies Private Limited (Director, since 16 Aug 2023).

Venkata Laxmi Irukulla was first appointed on 14 Sep 2020 as Director at Neuheit Pharma Technologies Private Limited. The most recent appointment on record is 22 Jul 2024 at Wiwin Health Care Private Limited.

The 2 current companies of Venkata Laxmi Irukulla that report revenue have a combined latest revenue of ₹1.25 Cr: Sri Rama Surya Constructions Private Limited ₹76.1 Lakh (FY 2025); Wiwin Health Care Private Limited ₹48.8 Lakh (FY 2024).

Venkata Laxmi Irukulla held 2 earlier board appointments: Neuheit Pharma Technologies Private Limited (Director, 14 Sep 2020 to 26 Feb 2024); Atindriya Solutions Llp (Designated Partner, from 09 Nov 2021).

The current boards of Venkata Laxmi Irukulla's companies include Dhavala Bhanu Priya (Sri Rama Surya Constructions Private Limited), Mantha V M Surya Bharadwaj (Sri Rama Surya Constructions Private Limited), Vamshi Krishna Vobalaboina (Sri Rama Surya Constructions Private Limited), Krishanakant Tulsiram Gandhi (Wiwin Health Care Private Limited), Rajkumar Bhimrao Shinde (Wiwin Health Care Private Limited), Rupali Krishnkant Gandhi (Wiwin Health Care Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available